R&D Advance Funding: Accelerate Your Tax Credit
R&D advance funding allows UK limited companies to borrow against a confirmed or expected HMRC R&D tax credit before the repayment lands. Specialist lenders typically advance 70 to 85 percent of the anticipated credit, with repayment drawn directly from the HMRC payment. It is a practical route for cash-flow-conscious businesses that cannot wait six to twelve months for HMRC to process a claim.
What R&D Advance Funding Is
R&D advance funding is a short-term facility secured against a company's R&D tax credit receivable, allowing the business to access most of the cash months before HMRC issues the repayment. The lender takes an assignment over the tax credit proceeds and is repaid automatically when HMRC transfers the funds, usually within three to nine months.
The product is not a grant and is not connected to the R&D scheme itself. It is a debt instrument offered by specialist finance houses and a small number of alternative lenders. Unlike an unsecured loan, the credit receivable acts as the primary collateral, which means many lenders place less weight on trading history or balance-sheet strength when underwriting the facility.
Eligibility: Who Qualifies
A company qualifies for an R&D advance when it has a credible, documented R&D tax credit claim that has either been submitted to HMRC or is ready for submission with a qualified agent or accountant overseeing it. Lenders want to see the claim has been prepared under SME Relief or the merged RDEC scheme introduced from April 2024.
Most lenders require the company to be a UK limited company, to have filed accounts with Companies House, and to have no winding-up petition or administration order in place. Sole traders and general partnerships are not eligible. A minimum claim value of around £20,000 is a common threshold, though some lenders will consider smaller amounts. Lenders will also review whether the R&D activities meet HMRC's definition and whether the underlying expenditure is properly evidenced, since a clawback obligation could fall to the lender if HMRC rejects the claim.
Advance Rates and Typical Costs
Advance rates typically fall between 70 and 85 percent of the anticipated credit, with the withheld portion acting as a buffer against HMRC queries, partial enquiries, or adjustments to the claim value.
Pricing is usually expressed as a monthly fee or a flat arrangement fee rather than an annual percentage rate, partly because the facility is short-term by design. A monthly fee of 1.5 to 3 percent on the drawn balance is common across the market, though rates vary depending on claim size, quality of the R&D documentation, and whether an established accountancy firm has prepared the submission. Arrangement fees of 1 to 2 percent of the facility are also standard. Because the facility is typically repaid within six to nine months, the effective annualised cost can look high relative to a term loan, but the comparison is not always like-for-like given the short tenor and the absence of hard collateral.
How the Process Works in Practice
The typical process from application to drawdown takes five to fifteen working days, making it considerably faster than most asset finance or commercial mortgage facilities. The key steps involve submitting the claim documentation to the lender, who will carry out their own technical and financial review before issuing a facility offer.
Once agreed, the company signs a deed of assignment that transfers the right to receive the HMRC repayment to the lender. The company or its accountant notifies HMRC of the assignment and confirms the repayment bank account is updated to the lender's nominated account. When HMRC processes the claim and releases funds, the lender deducts the principal, fees, and any accrued charges, then remits the balance to the borrower. It is worth confirming with your R&D tax adviser that the assignment process is handled correctly, since errors in the HMRC notification can delay repayment and increase the cost of the facility.
R&D Advance vs Waiting for HMRC Repayment
The core trade-off is straightforward: accepting a funding cost of roughly 10 to 20 percent of the claim value in exchange for receiving cash three to nine months earlier than HMRC would otherwise deliver it.
For businesses with strong cash flow and no immediate capital need, waiting costs nothing and retains the full credit. For businesses carrying supplier arrears, PAYE obligations, or a project pipeline that needs funding now, the advance can be commercially rational. It also avoids diluting equity through a fundraising round or drawing on an overdraft that may carry its own security requirements. The decision should be modelled against the actual cost of the delay, including any late payment penalties, foregone project revenue, or alternative borrowing costs the company would otherwise incur while waiting for the HMRC payment.
Post-April 2024 Merged Scheme Considerations
From April 2024 HMRC merged the SME R&D Relief and RDEC schemes into a single merged RDEC-style scheme for most companies, with a separate SME intensive scheme for loss-making R&D-intensive businesses. These changes affect the credit rates and tax treatment of claims, and lenders are adapting their underwriting accordingly.
Under the merged scheme the headline credit rate is 20 percent of qualifying expenditure, giving a net benefit of around 15 percent after corporation tax for a profitable company. The enhanced SME intensive route offers a credit rate of 27 percent for eligible companies. Lenders reviewing claims prepared under the new rules will look closely at whether the company has correctly identified its scheme and whether the expenditure categories align with the updated eligible cost rules, particularly around overseas contractor costs which became more restricted. Working with an R&D specialist accountant who is current with the post-2024 rules reduces the risk of a partial enquiry that could affect the advance repayment timeline.
Choosing a Lender
A small number of dedicated R&D advance lenders dominate this market in the UK, alongside some broader alternative finance providers who offer the product as part of a wider receivables or tax finance range. Choosing the right provider involves comparing advance rates, monthly fees, arrangement costs, and the lender's own process for handling HMRC enquiries should one arise during the facility period.
It is worth asking prospective lenders how they handle a scenario where HMRC opens a compliance check or reduces the credit during processing. Some lenders will require the borrower to top up any shortfall from other funds; others absorb a defined level of reduction within the withheld buffer. Brokers who specialise in tax finance can provide access to multiple lenders and negotiate terms based on claim size and quality, which is useful for first-time borrowers who have no existing lender relationship in this segment.
| Claim Size (£) | Typical Advance Rate | Estimated Advance (£) | Monthly Fee Range | Typical Facility Term |
|---|---|---|---|---|
| 20,000 to 50,000 | 70% | 14,000 to 35,000 | 2.5% to 3.0% | 4 to 9 months |
| 50,001 to 150,000 | 75% | 37,500 to 112,500 | 2.0% to 2.5% | 4 to 9 months |
| 150,001 to 500,000 | 80% | 120,000 to 400,000 | 1.5% to 2.0% | 3 to 9 months |
| 500,001 and above | 80% to 85% | 400,000+ | 1.25% to 1.75% | 3 to 9 months |
Step-by-step
- Confirm your R&D tax credit claim is prepared or ready for submission under the correct post-2024 scheme with a qualified adviser.
- Gather supporting documentation: the claim report, R&D expenditure schedule, filed or draft company accounts, and Companies House confirmation.
- Approach one or more specialist R&D advance lenders or a tax finance broker to obtain indicative terms based on claim size and quality.
- Review the facility offer: compare the advance rate, monthly fee, arrangement fee, and the lender's policy on HMRC enquiries or claim reductions.
- Sign the facility agreement and execute the deed of assignment transferring the HMRC repayment right to the lender.
- Notify HMRC of the assignment and update the nominated repayment bank account to the lender's account as instructed.
- Receive the advance drawdown. When HMRC processes the claim, the lender deducts principal and fees and remits the remaining balance to your account.
Example
A software development company with twelve employees submitted a merged-scheme R&D claim of £95,000 for the year ended March 2025. Rather than wait an estimated seven months for the HMRC repayment, the directors arranged an R&D advance at 75 percent, receiving £71,250 within ten working days. The funds were used to clear a supplier invoice backlog and part-fund a new development contract. When HMRC paid out four months later, the lender deducted principal, a 2 percent arrangement fee, and four months of charges, returning just over £16,000 to the company.
Frequently asked questions
Does taking an R&D advance affect the R&D claim itself?
No. The advance is a separate financing arrangement and has no bearing on the validity or value of the underlying R&D tax credit claim. HMRC processes the claim in the normal way. The deed of assignment simply redirects the repayment to the lender rather than to the company's own bank account.
What happens if HMRC reduces or rejects the claim after the advance has been paid?
If HMRC reduces the claim, the withheld buffer is intended to absorb a moderate shortfall. If the reduction exceeds the buffer, the borrower is typically required to repay the difference from other funds. A full rejection is rare but would make the full advance repayable by the company. This risk underlines the importance of using a qualified R&D adviser to prepare the claim documentation thoroughly before approaching a lender.
Can a loss-making company use R&D advance funding?
Yes, provided the company has a genuine R&D credit receivable. Loss-making companies claiming under the SME intensive scheme receive a payable credit from HMRC rather than a corporation tax reduction, which is precisely the receivable that lenders will advance against. The credit still needs to be properly documented and submitted.
How long does it take to receive funds?
Most specialist lenders complete their review and issue funds within five to fifteen working days of receiving a complete application pack. The main variables are the completeness of the claim documentation, the lender's own workload, and how quickly the deed of assignment and HMRC notification are executed. Delays in updating the HMRC payment account are a common cause of slow drawdown.
Is R&D advance funding regulated by the FCA?
Not directly. R&D advance funding is typically structured as a business-to-business receivables assignment rather than a regulated credit agreement, and most borrowers are limited companies rather than consumers. Lenders in this space are not generally required to hold FCA authorisation for this specific product, though some operate under broader FCA permissions. Companies should carry out their own due diligence on any lender and take independent financial advice if uncertain.
By Oliver Mackman, Director, Best Business Loans Ltd. Last reviewed 2026-05-30.